GLP-1 Weight Loss Drugs: Ozempic’s Role in Modern Weight Management
Revolutionizing Obesity Treatment: The Emergence of GLP-1 Agonists In the evolving landscape of obesity management, GLP-1 receptor agonists have emerged as transformative pharmacological agents, fundamentally altering therapeutic paradigms. Among these, Ozempic (semaglutide) stands out for its robust efficacy and growing clinical adoption. This class of drugs leverages the incretin effect to modulate appetite and glucose … Read more